Effectiveness and Tolerability of an Oral Nutritional Supplement (PreOP Booster) Given Before Surgery
Efficacy and Tolerability of a Preoperative Oral Nutritional Supplement (PreOP Booster) vs. Placebo in Surgical Patients (Pilot Study)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Alkmaar, Netherlands
- Medical Center Alkmaar
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- rectal tumour with indication for elective low anterior resection (open surgery, not laparoscopic surgery) or abdominoperineal resection (APR)
- preoperative radiotherapy (5x5 Gy) or chemoradiation
- loop ileostoma or colostoma;
Exclusion Criteria:
- severe malnutrition
- severe renal insufficiency
- diabetes mellitus I or II
- concomitant thyroid medication
- corticosteroids
- diuretic medication and antihypertensive medication
- known or suspected allergy to any component of the investigational product(s)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Test
Oral nutritional supplement: assignment according to consecutive random numbers.
|
3x1 dosage is given prior to surgery: 2x1 the day prior to surgery; 1x1 3-4h prior to initiation of anaesthesia;
|
|
Placebo Comparator: Control
Assignment according to consecutive random numbers.
|
3x1 dosage is given prior to surgery: 2x1 the day prior to surgery; 1x1 3-4h prior to initiation of anaesthesia;
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Immunoinflammatory parameters
Time Frame: on day -2, -1, 1, 2, 3, 5, and 7
|
on day -2, -1, 1, 2, 3, 5, and 7
|
|
Antioxidant / oxidant parameters
Time Frame: on day -2, 1, 3, 5, and 7
|
on day -2, 1, 3, 5, and 7
|
|
Ischemia / reperfusion injury parameters
Time Frame: on day -2, 1, 3, 5, and 7
|
on day -2, 1, 3, 5, and 7
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
pre-and postoperative discomfort (well-being)
Time Frame: on day -1, and 0
|
on day -1, and 0
|
|
hand grip strength
Time Frame: on day -2, 1, 2, 3, 5, and 7
|
on day -2, 1, 2, 3, 5, and 7
|
|
GI tolerance
Time Frame: on day -1, 0, 1, 2, and 7
|
on day -1, 0, 1, 2, and 7
|
|
Safety
Time Frame: on day -1, 0, 1, 2, 3, 5, and 7
|
on day -1, 0, 1, 2, 3, 5, and 7
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Paul A.M. van Leeuwen, Prof., University Hospital Amsterdam; The Netherlands
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- N-POB-04-NL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.